REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 67 filers reported holding REPARE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,098,415 | -25.3% | 106,127 | -9.9% | 0.00% | -100.0% |
| Q2 2023 | $1,470,444 | -23.4% | 117,824 | -8.5% | 0.00% | 0.0% |
| Q4 2022 | $1,919,522 | +14.5% | 128,827 | -3.8% | 0.00% | 0.0% |
| Q3 2022 | $1,676,000 | -13.5% | 133,895 | -2.9% | 0.00% | 0.0% |
| Q2 2022 | $1,937,000 | -3.0% | 137,855 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $1,997,000 | -34.4% | 138,655 | +0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,044,000 | -30.6% | 138,606 | -9.6% | 0.00% | 0.0% |
| Q3 2021 | $4,387,000 | -35.3% | 153,288 | -23.1% | 0.00% | -33.3% |
| Q2 2021 | $6,780,000 | -14.8% | 199,388 | -22.4% | 0.00% | -40.0% |
| Q1 2021 | $7,958,000 | -13.5% | 256,803 | +17.7% | 0.01% | -16.7% |
| Q4 2020 | $9,196,000 | +8828.2% | 218,167 | +5300.2% | 0.01% | – |
| Q3 2020 | $103,000 | +281.5% | 4,040 | +295.3% | 0.00% | – |
| Q2 2020 | $27,000 | – | 1,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |